The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical Development View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-12

AUTHORS

Thomas Ichim, Neil H Riordan, David F Stroncek

ABSTRACT

In mid November the biopharma industry was shocked by the announcement from Geron that they were ending work on embryonic stem cell research and therapy. For more than 10 years the public image of all stem cell research has been equated with embryonic stem cells. Unfortunately, a fundamentally important medical and financial fact was being ignored: embryonic stem cell therapy is extremely immature. In parallel to efforts in embryonic stem cell research and development, scientists and physicians in the field of adult stem cells realized that the natural role of adult stem cells in the body is to promote healing and to act like endogenous "repair cells" and, as a result, numerous companies have entered the field of adult stem cell therapy with the goal of expanding numbers of adult stem cells for administration to patients with various conditions. In contrast to embryonic stem cells, which are extremely expensive and potentially dangerous, adult cell cells are inexpensive and have an excellent safety record when used in humans. Many studies are now showing that adult stem cells are practical, patient-applicable, therapeutics that are very close to being available for incorporation into the practice of medicine. These events signal the entrance of the field of stem cells into a new era: an era where hype and misinformation no longer triumph over economic and medical realities. More... »

PAGES

218

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1479-5876-9-218

DOI

http://dx.doi.org/10.1186/1479-5876-9-218

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021122772

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22185188


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1004", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Industry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Embryonic Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stem Cell Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Universities", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "MediStem Inc, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ichim", 
        "givenName": "Thomas", 
        "id": "sg:person.0674333307.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674333307.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aidan Foundation", 
          "id": "https://www.grid.ac/institutes/grid.490741.f", 
          "name": [
            "Aidan Foundation, Chandler, AZ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Riordan", 
        "givenName": "Neil H", 
        "id": "sg:person.01236421105.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236421105.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes of Health Clinical Center", 
          "id": "https://www.grid.ac/institutes/grid.410305.3", 
          "name": [
            "Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stroncek", 
        "givenName": "David F", 
        "id": "sg:person.010511471377.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010511471377.03"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2011-12", 
    "datePublishedReg": "2011-12-01", 
    "description": "In mid November the biopharma industry was shocked by the announcement from Geron that they were ending work on embryonic stem cell research and therapy. For more than 10 years the public image of all stem cell research has been equated with embryonic stem cells. Unfortunately, a fundamentally important medical and financial fact was being ignored: embryonic stem cell therapy is extremely immature. In parallel to efforts in embryonic stem cell research and development, scientists and physicians in the field of adult stem cells realized that the natural role of adult stem cells in the body is to promote healing and to act like endogenous \"repair cells\" and, as a result, numerous companies have entered the field of adult stem cell therapy with the goal of expanding numbers of adult stem cells for administration to patients with various conditions. In contrast to embryonic stem cells, which are extremely expensive and potentially dangerous, adult cell cells are inexpensive and have an excellent safety record when used in humans. Many studies are now showing that adult stem cells are practical, patient-applicable, therapeutics that are very close to being available for incorporation into the practice of medicine. These events signal the entrance of the field of stem cells into a new era: an era where hype and misinformation no longer triumph over economic and medical realities.", 
    "genre": "non_research_article", 
    "id": "sg:pub.10.1186/1479-5876-9-218", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4055452", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4055194", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1032886", 
        "issn": [
          "1479-5876"
        ], 
        "name": "Journal of Translational Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "name": "The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical Development", 
    "pagination": "218", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "64a3c7a093050419484995ab90b039a5735e15a7ea576bace6afc3fd3ec70896"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22185188"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101190741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1479-5876-9-218"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021122772"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1479-5876-9-218", 
      "https://app.dimensions.ai/details/publication/pub.1021122772"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T13:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8659_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1479-5876-9-218"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-9-218'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-9-218'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-9-218'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-9-218'


 

This table displays all metadata directly associated to this object as RDF triples.

123 TRIPLES      20 PREDICATES      37 URIs      29 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1479-5876-9-218 schema:about N17b484d82ba74c6cbea093a3264c0252
2 N36679f2df4384956bc7103fb5b6c9d4e
3 N3ed4d43fdd784eaaa2f082530e844c95
4 N43957dc37e2b4b56bbd8ed55b0a234e8
5 N4fd87324f19545a5b071ebb0552bd50d
6 N71ac91b895244f06a15edf8876f6e4e3
7 N98b86b6659464330adb36852741ec0c7
8 Ne8282f2ae4f7473aa209a96f221aa1cf
9 anzsrc-for:10
10 anzsrc-for:1004
11 schema:author Nd579a65fb7104671ae40903e20404515
12 schema:datePublished 2011-12
13 schema:datePublishedReg 2011-12-01
14 schema:description In mid November the biopharma industry was shocked by the announcement from Geron that they were ending work on embryonic stem cell research and therapy. For more than 10 years the public image of all stem cell research has been equated with embryonic stem cells. Unfortunately, a fundamentally important medical and financial fact was being ignored: embryonic stem cell therapy is extremely immature. In parallel to efforts in embryonic stem cell research and development, scientists and physicians in the field of adult stem cells realized that the natural role of adult stem cells in the body is to promote healing and to act like endogenous "repair cells" and, as a result, numerous companies have entered the field of adult stem cell therapy with the goal of expanding numbers of adult stem cells for administration to patients with various conditions. In contrast to embryonic stem cells, which are extremely expensive and potentially dangerous, adult cell cells are inexpensive and have an excellent safety record when used in humans. Many studies are now showing that adult stem cells are practical, patient-applicable, therapeutics that are very close to being available for incorporation into the practice of medicine. These events signal the entrance of the field of stem cells into a new era: an era where hype and misinformation no longer triumph over economic and medical realities.
15 schema:genre non_research_article
16 schema:inLanguage en
17 schema:isAccessibleForFree true
18 schema:isPartOf N129377e3257548dab40ba4a8ea98a3b3
19 N9bb395b85c19401797b5b4126120d8a4
20 sg:journal.1032886
21 schema:name The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical Development
22 schema:pagination 218
23 schema:productId N4b829bfb46084becb39259200aaf8913
24 N4cfd8f3dbd6d406faf2eecbd84aa26d6
25 N7846367923604f05a3f3101cb08647a2
26 N903917dba55545e696e6c6ab1b46b766
27 Na88a6a5785994fbb9604f916b6a51018
28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021122772
29 https://doi.org/10.1186/1479-5876-9-218
30 schema:sdDatePublished 2019-04-10T13:16
31 schema:sdLicense https://scigraph.springernature.com/explorer/license/
32 schema:sdPublisher Ndfbbd1bb36ea4a409118e31c6e79f10c
33 schema:url http://link.springer.com/10.1186%2F1479-5876-9-218
34 sgo:license sg:explorer/license/
35 sgo:sdDataset articles
36 rdf:type schema:ScholarlyArticle
37 N129377e3257548dab40ba4a8ea98a3b3 schema:volumeNumber 9
38 rdf:type schema:PublicationVolume
39 N17b484d82ba74c6cbea093a3264c0252 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
40 schema:name Adult Stem Cells
41 rdf:type schema:DefinedTerm
42 N36679f2df4384956bc7103fb5b6c9d4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
43 schema:name Humans
44 rdf:type schema:DefinedTerm
45 N3ed4d43fdd784eaaa2f082530e844c95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
46 schema:name Drug Industry
47 rdf:type schema:DefinedTerm
48 N43957dc37e2b4b56bbd8ed55b0a234e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Embryonic Stem Cells
50 rdf:type schema:DefinedTerm
51 N4b8101e623f647d289b47a5e7810e7ad schema:name MediStem Inc, San Diego, CA, USA
52 rdf:type schema:Organization
53 N4b829bfb46084becb39259200aaf8913 schema:name readcube_id
54 schema:value 64a3c7a093050419484995ab90b039a5735e15a7ea576bace6afc3fd3ec70896
55 rdf:type schema:PropertyValue
56 N4cfd8f3dbd6d406faf2eecbd84aa26d6 schema:name doi
57 schema:value 10.1186/1479-5876-9-218
58 rdf:type schema:PropertyValue
59 N4fd87324f19545a5b071ebb0552bd50d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Stem Cell Research
61 rdf:type schema:DefinedTerm
62 N71ac91b895244f06a15edf8876f6e4e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Animals
64 rdf:type schema:DefinedTerm
65 N7846367923604f05a3f3101cb08647a2 schema:name nlm_unique_id
66 schema:value 101190741
67 rdf:type schema:PropertyValue
68 N903917dba55545e696e6c6ab1b46b766 schema:name dimensions_id
69 schema:value pub.1021122772
70 rdf:type schema:PropertyValue
71 N98b86b6659464330adb36852741ec0c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Universities
73 rdf:type schema:DefinedTerm
74 N9bb395b85c19401797b5b4126120d8a4 schema:issueNumber 1
75 rdf:type schema:PublicationIssue
76 Na88a6a5785994fbb9604f916b6a51018 schema:name pubmed_id
77 schema:value 22185188
78 rdf:type schema:PropertyValue
79 Nd28a209616f5458a8d55b9d759ae2e1b rdf:first sg:person.010511471377.03
80 rdf:rest rdf:nil
81 Nd579a65fb7104671ae40903e20404515 rdf:first sg:person.0674333307.06
82 rdf:rest Ne058bbadae674096824bdf2588094557
83 Ndfbbd1bb36ea4a409118e31c6e79f10c schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 Ne058bbadae674096824bdf2588094557 rdf:first sg:person.01236421105.18
86 rdf:rest Nd28a209616f5458a8d55b9d759ae2e1b
87 Ne8282f2ae4f7473aa209a96f221aa1cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Clinical Trials as Topic
89 rdf:type schema:DefinedTerm
90 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
91 schema:name Technology
92 rdf:type schema:DefinedTerm
93 anzsrc-for:1004 schema:inDefinedTermSet anzsrc-for:
94 schema:name Medical Biotechnology
95 rdf:type schema:DefinedTerm
96 sg:grant.4055194 http://pending.schema.org/fundedItem sg:pub.10.1186/1479-5876-9-218
97 rdf:type schema:MonetaryGrant
98 sg:grant.4055452 http://pending.schema.org/fundedItem sg:pub.10.1186/1479-5876-9-218
99 rdf:type schema:MonetaryGrant
100 sg:journal.1032886 schema:issn 1479-5876
101 schema:name Journal of Translational Medicine
102 rdf:type schema:Periodical
103 sg:person.010511471377.03 schema:affiliation https://www.grid.ac/institutes/grid.410305.3
104 schema:familyName Stroncek
105 schema:givenName David F
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010511471377.03
107 rdf:type schema:Person
108 sg:person.01236421105.18 schema:affiliation https://www.grid.ac/institutes/grid.490741.f
109 schema:familyName Riordan
110 schema:givenName Neil H
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236421105.18
112 rdf:type schema:Person
113 sg:person.0674333307.06 schema:affiliation N4b8101e623f647d289b47a5e7810e7ad
114 schema:familyName Ichim
115 schema:givenName Thomas
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674333307.06
117 rdf:type schema:Person
118 https://www.grid.ac/institutes/grid.410305.3 schema:alternateName National Institutes of Health Clinical Center
119 schema:name Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA
120 rdf:type schema:Organization
121 https://www.grid.ac/institutes/grid.490741.f schema:alternateName Aidan Foundation
122 schema:name Aidan Foundation, Chandler, AZ, USA
123 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...